Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PTC Therapeutics

Explore full profile

A science-led, patient-centered biopharmaceutical company focused on discovering, developing and commercializing medicine for patients with rare disease

South Plainfield, United StatesFounded 1998Biotech & Life Sciences
Valuation $4.14B Market cap · Aug/2026
Revenue $1.24B Latest reported FY
EBITDA $412M Latest reported FY

At a glance

Status
Listed
Founded
1998
Headquarters
South Plainfield, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News PTC Therapeutics prices $500M convertible notes, repurchases 2026 notes Jun 16, 2026

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later21 investors entered at this stage

  • HealthCap
  • Longwood Fund
  • HBM BioVentures
  • Jennison Associates
  • HBM Healthcare Investments
  • Novo Holdings
  • CDIB Capital Group
  • Rutgers university
  • Adage Capital
  • Credit Suisse First Boston
  • Delphi Ventures
  • Cercano Management
  • Manulife Financial
  • Bay City Capital
  • Celgene
  • Credit Suisse
  • New Medical Technologies
  • The Column Group
  • Amgen Ventures
  • Brookside Capital
  • CDI Bioscience

Talent

Book a demo to see the people
Employees mapped 1,150 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 8 startups shown

Former PTC Therapeutics employees who went on to found companies, sorted by Dealroom signal score.

Kailera TherapeuticsEst. 2024
Ron RenaudUnited States
Signal score95
Signify BioEst. 2024
RIRa Session IiUnited States
Signal score88
DispelEst. 2014
ESEthan SchmertzlerUnited States
Signal score85
PikralidaEst. 2019
Stanisław PikulPoland
Signal score72
Nionyx BioEst. 2025
MTMagdalena TyrpienUnited States
Signal score71
3 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
31 countries with
team presence
🇺🇸 United States69.9%
🇧🇷 Brazil7.6%
🇮🇪 Ireland4.9%
🇨🇭 Switzerland2.6%
🇬🇧 United Kingdom1.7%
Top 5 of 31 shown
Web traffic by country
54K monthly visits
across markets
🇺🇸 United States59.3%
🇬🇧 United Kingdom20.6%
🇨🇦 Canada5%
🇮🇳 India3.7%
🇫🇷 France2.2%
Top 5 markets shown

Patents

Estimated portfolio value
$168M

118 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PTC Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PTC Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles